Delivery Order SPE2DR25D1002-SPE2DR26FGR4F
Award Date 4/8/26
Potential Completion Date 4/29/26
Potential Value $1.6K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $9,894.60 delivery order to AmerisourceBergen Drug Corp on March 13, 2026, for HYPERRAB 300 unit/mL vial 5mL pharmaceutical product, with ultimate completion on April 3, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), a $999,999,999 vehicle through December 2026 that supplies pharmaceutical products and medical commodities to support military healthcare programs worldwide. Place of performance is...
- <p>The Defense Logistics Agency issued a $9,894.60 delivery order to AmerisourceBergen Drug Corp on April 8, 2026, for HYPERRAB 300 Unit/mL vial 5mL pharmaceutical supply.</p> <p>The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026. Place of performance is Conshohocken, PA. The order has a firm fixed price structure with an ultimate completion date of April 29, 2026.</p>
- The Defense Logistics Agency issued a $2,993.55 delivery order to Amerisourcebergen Drug Corp on April 6, 2026, for HYPERRAB 300 Unit/ML Vial 3ML pharmaceutical product. The order was placed under the DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at up to $999,999,999.00 through December 2026, which provides global pharmaceutical and medical supply support to military healthcare programs. Place of performance is Conshohocken, PA. Ultimate completion date is April 27,...
- The Defense Logistics Agency issued a $8,245.50 delivery order to Amerisourcebergen Drug Corp on March 11, 2026, for HYPERRAB 300 unit/ml vial 5ml pharmaceutical supply. This delivery order is issued under the DLA Troop Support Medical Indefinite Delivery Contract valued at up to $999,999,999.00 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. The order carries a firm fixed price...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on April 1, 2026, for HYPERRAB 300 unit/mL vial 5 mL with a ceiling value of $19,649.40. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026, which provides pharmaceutical products and medical supplies to support military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order is firm fixed...
- The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on March 17, 2026, for HYPERRAB 300 unit/mL vial 5mL with a ceiling value of $8,245.50. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) SPE2DX, a $999,999,999 global pharmaceutical supply vehicle through December 2026 supporting military healthcare programs. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with an ultimate...
- The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 11, 2026, with a ceiling value of $8,245.50 for HYPERRAB 300 unit/mL vial 5mL. This is a firm fixed-price delivery order under the Defense Logistics Agency Troop Support Medical IDC (SPE2DX), a $999,999,999 indefinite delivery contract running through December 2026 that supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is...
- The Defense Logistics Agency issued a $32,982 delivery order to AmerisourceBergen Drug Corp on March 16, 2026, for HYPERRAB 300 Unit/ML Vial 5ML, a rabies immunoglobulin product. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999 through December 2026, which provides pharmaceutical and medical supply support to military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate completion date is April 6,...
- The Defense Logistics Agency awarded a $1,790.80 delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of HYPERRAB 300 Unit/ML Vial 5ML, with completion targeted for October 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a continuation of the contractor's pharmaceutical supply services to the federal government. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of HYPERRAB 300 Unit/ML Vials, with a ceiling value of $4,158.12 and an ultimate completion date of November 25, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor...